Physician profile
William A Primos
NPI 1528040458
$787.81
in general payments reported to CMS, 2019-2025
18 companies · $53.95 in 2025
The $53.95 reported for 2025 was less than what a typical Sports Medicine (Pediatrics) provider received nationally (typical 2025 total: $59.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $155 · 2021: $28.13 · 2022: $40.73 · 2023: $171 · 2024: $107 · 2025: $53.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $332.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $150.79 | 2023-2024 | Euflexxa |
| Bioventus LLC | $121.08 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $65.53 | 2020-2021 | |
| Amarin Pharma, INC. | $57.00 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $54.82 | 2019-2020 | |
| Amgen INC. | $44.68 | 2019-2020 | |
| Heron Therapeutics, INC. | $43.18 | 2023-2024 | Zynrelef |
| Smith+Nephew, INC. | $43.11 | 2023 | Stravix, Grafix, Grafix Pl |
| Depuy Synthes Sales INC. | $30.05 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.44 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $28.33 | 2019 | |
| Baxter Healthcare | $27.58 | 2019 | |
| Pfizer INC. | $18.46 | 2019 | |
| Zyla Life Sciences, INC. | $17.65 | 2019 | |
| Endo Pharmaceuticals INC. | $17.41 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $14.80 | 2025 | Zilretta |
| Cranial Technologies, INC | $13.28 | 2020 | |
| Horizon Therapeutics Plc | $11.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Primos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.